A partnership between Aston University and contract medicine manufacturer Catalent has led to a faster process to identify the best ingredients for optimal medicine formulations, and has been rated as ...

A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight ...

The World Health Organization (WHO) today announced its recommendations for the viral composition of influenza vaccines for use in the 2026 influenza season in the southern hemisphere.

(RTTNews) - Clearmind Medicine Inc. (CMND), Wednesday announced that the company has signed a non-binding Letter of Intent with Polyrizon Ltd. (PLRZ), a development stage biotech company, to develop a ...

The Laboratory for Advanced Immunotechnologies and Formulation aims to explore and advance vaccine technologies to develop novel and improved vaccine solutions. "Amastigote" usually refers to the ...

The FDA will decide on whether to approve the first oral formulation of a GLP-1 (once-daily semaglutide 25 mg) for chronic ...

Aphaia’s lead formulation orchestrates a comprehensive hormonal response from nutrient-sensing cells with potential to modify the course of obesity and associated metabolic diseases.It is currently ...

Calgary, Alberta, Canada, September 5, 2024 –TheNewswire –Voyageur Pharmaceuticals Ltd (VM:CA). (USA: VYYRF) ("Voyageur" or the "Company") announces that in an innovative endeavor,it has completed ...

Laxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru’s Enobosarm, Utilizing Laxxon’s SPID®-Technology Laxxon Medical Corp., a leading ...

NEW YORK--(BUSINESS WIRE)-- Laxxon Medical Corp., a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced that Veru Inc. (VERU), ...